April 22, 2025CorporateTerumo unveils “Terumo Group Statement on Nature,” a guideline for its actions on conservation and restoration of natural environments
April 16, 2025CorporateTerumo Blood and Cell Technologies Names Patrick Daly as Chief Business OfficerDaly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth
April 16, 2025CorporateTerumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and patient comfort –
FYE 3/2024 FYE 3/2023 FYE 3/2022 FYE 3/2020 FYE 3/2019 FYE 3/2018 FYE 3/2017 FYE 3/2024 Consolidated Financial Statements (PDF 1.11 MB) FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB) FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB) FYE 3/2020 Consolidated Financial Statements (PDF 1.48 MB) FYE 3/2019 Consolidated Financial Statements (PDF 1.52 MB) FYE 3/2018 Consolidated Financial Statements (PDF 1.77 MB) FYE 3/2017 Consolidated Financial Statements (PDF 2.93 MB) Adobe Reader (free) is required to view PDF files. Download Adobe Reader
FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB)
FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB)
Top
Top